Send us Feedback

Corcept Therapeutics (CORT)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Cash & Equivalents 42.6M 34.9M 102M 93.0M 81.5M
Short Term Investments 0 0 0 0 0
Accounts Receivable 0 355K 354K 557K 1.14M
Inventories 56.0K 2.44M 1.84M 853K 1.03M
Pre-paid Expenses 102K 608K 800K 620K 572K
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 0 0 0 0
Total Current Assets 42.8M 38.3M 105M 95.1M 84.2M
Property, Plant & Equipment 30.0K 59.0K 105K 150K 154K
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 72.0K 260K 800K 3.95M 3.79M
Total Long-Term Assets 102K 319K 905K 4.10M 3.94M
Total Assets 42.9M 38.6M 106M 99.2M 88.1M
Accounts Payable 2.08M 4.24M 1.57M 3.80M 2.26M
Accrued Expenses 0 0 0 0 0
Short Term Debt 0 0 2.25M 2.65M 3.90M
Other Current Liabilities 0 26.0K 21.0K 16.0K 76.0K
Total Current Liabilities 3.57M 5.82M 5.55M 8.36M 8.24M
Long Term Debt 0 0 28.3M 29.0M 28.9M
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 0 0 0 0 0
Total Long-term Liabilities 0 0 28.3M 29.0M 28.9M
Minority Interest 0 0 0 0 0
Total Liabilities 3.57M 5.82M 33.9M 37.4M 37.1M
Preferred Stock 0 0 0 0 0
Common Par 89.0K 89.0K 100K 100K 100K
Additional Paid-In Capital 259M 260M 307M 308M 310M
Retained Earnings -220M -227M -235M -247M -259M
Treasury Stock 0 0 0 0 0
Other Equity 0 0 0 0 0
Total Shareholder's Equity 39.3M 32.8M 71.7M 61.8M 51.0M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki